Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway

Fig. 3

PPARγ agonists induced cell cycle G2 arrest in bladder cancer cells. (a) Cell cycle determined with flow cytometry in Umuc-3 cells. (b) Cell cycle determined with flow cytometry in 5637 cells. (c) Cell cycle distribution Umuc-3 cells. (d) Cell cycle distribution in 5637 cells. Umuc-3 and 5637 cells were treated with pioglitazone, rosiglitazone, T0070907, and GW9662 (10, 20 μM) for 72 h

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us